lys arg ala lys ala lys thr thr lys lys arg

Fmoc-Lys-OH hydrochloride 是一种基于烷基链的 PROTAC linker。 Fmoc-Lys-OH hydrochloride 是一种不可降解的 ADC linker，用于合成抗体-药物偶联物 (ADC)。

Mc-​Val-​Ala-​PAB 是一种可降解的 ADC 接头，用于抗体-药物偶联物。

Fmoc-Val-Ala-PAB-OH (Fmoc-Val-Ala-PAB) 是一种有用的接头，可用于制备用于靶向药物递送的抗体-药物偶联物。它还用于合成带有溶酶体可切割接头的 RGD 拟肽-紫杉醇缀合物。

Lys-SMCC-DM1 (Lys-Nε-MCC-DM1) 是一种靶向人表皮生长因子受体2 (HER2) 的 ADC，作为 T-DM1 的活性代谢产物含有微管蛋白聚合抑制剂 DM1，可抑制微管蛋白聚合，常用于乳腺癌的研究。

MC-Val-Ala-PAB-PNP 是一种用于合成抗体偶联药物的 linker，可降解。

Phe-Lys(Trt)-PAB 是一种组织蛋白酶可裂解的 ADC 接头，用于合成抗体-药物偶联物。

Fmoc-Ala-Ala-Asn(Trt)-OH 是一种可切割的 ADC 接头，用于抗体-药物偶联物。

Boc-Phe-(Alloc)Lys-PAB-PNP serves as a cleavable linker in the synthesis of antibody-drug conjugates (ADCs).

m-PEG-Lys-NHS ester (MW 20000) is an alkyl ether-based PROTAC linker commonly employed in PROTAC synthesis[1].

NH2-PEG4-Lys(Boc)-NH-(m-PEG24) is a 28-unit polyethylene glycol (PEG) linker containing a cleavable bond, commonly employed in the production of antibody-drug conjugates (ADCs)[1].

Boc-Val-Ala-PAB-PNP is an ADC linker employed for the synthesis of antibody-drug conjugates (ADCs)[1]. This cleavable compound efficiently facilitates the attachment of drugs to antibodies, allowing for targeted delivery and release of therapeutic agents within the body, making it an important component in ADC development.

N'-Boc-N-(Gly-Oleoyl)-Lys is an alkyl chain-derived proteolysis targeting chimera (PROTAC) linker suitable for PROTAC synthesis [1].

Oleoyl-Gly-Lys-N-(m-PEG11) is a cleavable 11 unit PEG linker utilized for the synthesis of antibody-drug conjugates (ADCs)[1].

Fmoc-Lys (biotin-PEG4)-OH is a biotinylated and PEG-modified PROTAC linker utilized for PROTAC synthesis[1].

Mal-PEG4-Lys(t-Boc)-NH-m-PEG24 is a polyethylene glycol (PEG)-based PROTAC linker, suitable for the synthesis of PROTACs[1].

Fmoc-Lys (biotin-PEG12)-OH is a PEGylation-based linker compound utilized in PROTAC synthesis[1].

Azide-PEG3-C1-Ala is a PEG-based linker for PROTACs which joins two essential ligands, crucial for forming PROTAC molecules. This linker enables selective protein degradation by leveraging the ubiquitin-proteasome system within cells.

Fmoc-Ala-Ala-Asn-PABC-PNP is a cleavable peptide ADC linker [1].

Fmoc-PEG3-Ala-Ala-Asn(Trt)-PAB is a cleavable three-unit polyethylene glycol (PEG) linker employed in the synthesis of antibody-drug conjugates (ADCs)[1].

Mal-PEG4-Lys(TFA)-NH-m-PEG24 is a polyethylene glycol (PEG) derivative specifically designed as a PROTAC linker for the synthesis of proteolysis targeting chimeras (PROTACs) [1].

Azido-PEG3-Ala-Boc is a PEG-based linker for PROTACs which joins two essential ligands, crucial for forming PROTAC molecules. This linker enables selective protein degradation by leveraging the ubiquitin-proteasome system within cells.

Ala-Ala-Asn-PAB is a cleavable peptide linker used in antibody-drug conjugates (ADCs)[1].

'(Ac)Phe-Lys(Alloc)-PABC-PNP serves as a valuable cleavable linker in the development of antibody-drug conjugates.'

Phe-Lys(Fmoc)-PAB is a cathepsin cleavable ADC linker employed in the conjugation of antibody-drug conjugates (ADCs)[1].

Fmoc-Lys(Pal-Glu-OtBu)-OH 是一种有用的有机化合物，可用于生命科学领域的相关研究。其产品编号为 T66786，CAS号为 1491158-62-3。

Aloc-D-Ala-Phe-Lys(Aloc)-PAB-PNP is a cleavable linker utilized in the synthesis of antibody-drug conjugates (ADCs), which are innovative therapeutic agents that combine the targeting ability of antibodies with potent cytotoxic drugs.

Azido-PEG5-Ala-Ala-Asn-PAB is a cleavable 5-unit polyethylene glycol (PEG) linker employed in the synthesis of antibody-drug conjugates (ADCs)[1].

Fmoc-Phe-Lys(Trt)-PAB-PNP is a cleavable linker for antibody-drug conjugate (ADC) synthesis, specifically designed for use in ADC synthesis.

Fmoc-PEG4-Ala-Ala-Asn-PAB is a four-unit polyethylene glycol (PEG) linker, cleavable in nature. It is specifically employed for the synthesis of antibody-drug conjugates (ADCs)[1].

Fmoc-Phe-Lys(Boc)-PAB-PNP is a cleavable antibody-drug conjugate (ADC) linker employed in the synthesis of ADCs.

Cbz-Phe-(Alloc)Lys-PAB-PNP serves as a cleavable linker in the design of antibody-drug conjugates (ADC).

Comp Ie (MC-(β-Ala)-PABC-(β-D-GlcUA)-amide-PEG1-CH2-CC-885) 为一种新型抗体新降解剂偶联活性分子 (AnDC) 的合成降解剂偶联物。

Mc-Leu-Gly-Arg is a cleavable ether linker for antibody-drug conjugates (ADC) design.

m-PEG-Lys-NHS ester (MW 40000) is an alkyl ether-based PROTAC linker utilized for the synthesis of PROTACs[1].